IRVINE, Calif. & NEW YORK--(BUSINESS WIRE)--BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced a variety of advances and activities for the upcoming Greater New York Dental Meeting 2014 including the introduction of a new generation EPIC X diode laser, designed to be the premier and complete diode laser for the whole dental team. The Greater New York Dental Meeting, billed as the largest dental congress and exposition in the U.S., will be held from Friday, Nov. 28-Wednesday, Dec. 3, at the Jacob K. Javits Convention Center in New York City. The Exhibits at the meeting will be open from Sunday, Nov. 30-Wednesday Dec. 3.
In addition, Samuel Low, DDS, the Chairman of the Company’s new Dental Professional Advisory Board, will provide a training session on the EPIC X (diode) and on the flagship WaterLase® iPlus (All-Tissue) lasers, during the meeting.
BIOLASE will showcase its entire line of products at the meeting, including the WaterLase® iPlus, and, as a special activity, will feature Cirque du Soleil performers at its Booth #600. The Cirque du Soleil performers will appear at 11 a.m., noon, 1 p.m. and 2 p.m. daily starting Sunday.
The new generation EPIC X diode laser demonstrates the Company’s ability to listen closely to its customers and respond to their needs and the needs of the marketplace with high-quality, reliable, customer-preferred products, noted President and CEO Jeffrey M. Nugent.
“We believe the new EPIC X diode laser is a prime example of how the three pillars of the new BIOLASE, which include customer satisfaction, quality in everything we do and disciplined innovation, will benefit dentists worldwide,” Nugent said. “It’s exciting to see the transformation that is going on within BIOLASE and we invite you to stop by our booth and see for yourself. It’s a new day at BIOLASE so please join us.”
The EPIC X, the newest generation of the Company’s award-winning EPIC diode lasers for dentists and hygienists, features new software technology and a new cordless foot pedal, among other notable innovations. The EPIC X offers fast access, fast whitening and hygiene versatility along with its features such as exclusive Pain Therapy treatment modes, simplified user controls and enhanced ComfortPulse™ settings to deliver greater patient comfort. The EPIC X was created to be the most versatile, most responsive and most portable diode laser on the market so dentists can delight their patients, faster.
Along with the Cirque du Soleil performers, the Company will also host a variety of promotions and activities at its Booth #600.
A series of live patient courses and lectures will also be held including:
- “The Total Technology Solution: Take Your Practice to the Cutting Edge,’ presented by Howard Golan, DDS, from 9 a.m.-Noon, and 2-5 p.m. on Sunday, Nov. 30
- “Using Dental Lasers in Today’s World,” a lecture presented by Samuel Low, DDS, from 9 a.m.-noon on Monday, Dec. 1
- “Utilizing Laser Technology in a Periodontal Environment,” a laser hands-on course presented by Samuel Low, DDS, from 2-5 p.m. on Monday, Dec. 1.
For more information, visit Booth #600 or call 888-4-BIOLASE (888-424-6527).
About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical device company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment, CAD/CAM intraoral scanners, and in-office milling machines and 3D printers. BIOLASE’s products are focused on technologies that advance the practice of dentistry and medicine and offer benefits and value to healthcare professionals and their patients. The Company's proprietary laser products incorporate approximately 300 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 26,000 laser systems. Laser products under development address the Company’s core dental market and other adjacent medical and consumer markets.
For updates and information on WaterLase and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Pinterest at www.pinterest.com/biolase, LinkedIn at www.linkedin.com/company/biolase, Google+ at www.google.com/+BIOLASEIrvine, Instagram at www.instagram.com/biolaseinc, and YouTube at www.youtube.com/biolasevideos.
BIOLASE® and WaterLase® are registered trademarks of BIOLASE, Inc.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Statements contained in this press release that refer to BIOLASE's estimated or anticipated future results or other non-historical facts are forward-looking statements, as are any statements in this press release concerning prospects related to BIOLASE's strategic initiatives and anticipated financial performance. Forward-looking statements can also be identified through the use of words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “will,” and variations of these words or similar expressions. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect BIOLASE's current perspective of existing trends and information and speak only as of the date of this release. Actual results may differ materially from BIOLASE’s current expectations depending upon a number of factors affecting BIOLASE’s business. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business, and those other risks and uncertainties that may be detailed, from time-to-time, in BIOLASE's reports filed with the SEC. BIOLASE does not undertake any responsibility to revise or update any forward-looking statements contained herein.